10x Genomics, Inc.

NASDAQ:TXG

15.68 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -255.099-166-58.223-542.731-31.251-112.485-18.762
Depreciation & Amortization 43.61933.00628.25419.0217.0663.9054.305
Deferred Income Tax -262.947001.550.6140.2510
Stock Based Compensation 166.95136.84895.96248.62613.3332.6581.661
Change In Working Capital 17.343-39.417-87.445-50.38144.76428.0151.948
Accounts Receivables -10.613-18.948-34.041-17.847-5.284-14.747-5.131
Inventory 7.871-21.192-30.132-14.601-6.699-3.732-1.995
Accounts Payables -6.0175.85811.084-7.774.9012.5873.034
Other Working Capital 26.102-5.135-34.356-10.16351.84643.9076.04
Other Non Cash Items 274.9371.9570.079306.0170.1011.2470.149
Operating Cash Flow -15.197-33.606-21.373-217.89834.627-76.409-10.699
Investing Activities:
Investments In Property Plant And Equipment -49.524-131.661-101.278-38.394-42.767-6.709-3.756
Acquisitions Net 0-4-5.4510000
Purchases Of Investments 0-282.87100000
Sales Maturities Of Investments 183.01667.64500000
Other Investing Activites -0-215.2260-1.728-0.025-0.4250
Investing Cash Flow 133.492-350.887-106.729-38.394-42.767-6.709-3.756
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 19.48321.22640.325506.01410.8241.79821.056
Common Stock Repurchased 000000-0.08
Dividends Paid 0000000
Other Financing Activities -5.814-5.409-5.028506.0114.766104.34221.056
Financing Cash Flow 13.66915.81735.297468.906414.59105.36720.583
Other Information:
Effect Of Forex Changes On Cash -0.033-0.0440.234-0.463-0.045-0.018-0.014
Net Change In Cash 136.905-368.72-92.571212.151406.40522.2316.114
Cash At End Of Period 359.284227.353596.073688.644476.49370.08847.857